| 英文名稱(chēng) |
中文名稱(chēng) |
CAS號(hào) |
操作 |
| ICAM-3, Human Recombinant |
|
|
詳細(xì)
|
| IdoA2S-GlcNS6S, 4Na (I2S6) |
|
|
詳細(xì)
|
| IFN-beta, Mouse, Recombinant (CHO-derived), 5 x 10E4 units |
|
|
詳細(xì)
|
| IdoA-GlcNS6S, 3Na (I0S6) |
|
|
詳細(xì)
|
| IFN-alpha, Mouse, mAb F18, 100 ug |
|
|
詳細(xì)
|
| IdoA2S-GlcNS, 3Na (I2S0) |
|
|
詳細(xì)
|
| IgG2a, Rat, mAb RTK2758, Isotype ctrl, Low Endotoxin, 500 ug |
|
|
詳細(xì)
|
| IFN-gamma, Human, mAb F12, 300 ug |
|
|
詳細(xì)
|
| IDO1, Rat, pAb, 100 ug |
|
|
詳細(xì)
|
| IL-12 (Interleukin 12) GMP, CF |
|
|
詳細(xì)
|
| IL-20, mouse recombinant |
|
|
詳細(xì)
|
| i-Fect |
|
|
詳細(xì)
|
| IdoA-GlcNS, 2Na (I0S0) |
|
|
詳細(xì)
|
| IL-12B p40, Human, pAb, 100 ul |
|
|
詳細(xì)
|
| IgG1, Mouse, mAb MOPC-21, Isotype control, R-PE, 25 ug |
|
|
詳細(xì)
|
| IL-FABP, Human, pAb, 100 ug |
|
|
詳細(xì)
|
| IL-10, Human, pAb, 20 ug |
|
|
詳細(xì)
|
| IL-5, murine recombinant |
|
|
詳細(xì)
|
| IgG1, Ms, mAb MOPC-21, Isotype ctrl, Ultra Low Endotox, 1 mg |
|
|
詳細(xì)
|
| IgG2a, Rat, mAb RTK2758, Isotype control, 50 ug |
|
|
詳細(xì)
|
| IL-FABP, Human, pAb, 20 ug |
|
|
詳細(xì)
|
| IL-7 GMP, CF |
|
|
詳細(xì)
|
| IL-33, Human, pAb, 100 ul |
|
|
詳細(xì)
|
| Immunoglobulin E(IgE) human serum (3rd International Standard) |
|
|
詳細(xì)
|
| IMEMS Random Nanofibers 6 Chambers |
|
|
詳細(xì)
|
| IL-22, Human, pAb, 100 ul |
|
|
詳細(xì)
|
| IGRP Catalytic Subunit (206-214) |
|
|
詳細(xì)
|
| IL-6/IL-6R alpha, Chimera |
|
|
詳細(xì)
|
| IL-15 GMP, CF |
|
|
詳細(xì)
|
| IgG1, Ms, mAb MOPC-21, Isotype ctrl, Low Endotoxin, 500 ug |
|
|
詳細(xì)
|
| Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent |
|
|
詳細(xì)
|
| Influenza antiserum A/Anhui/1/05 (H5) |
|
|
詳細(xì)
|
| Influenza anti A/Panama/2007/99 Serum |
|
|
詳細(xì)
|
| Interleukin-1 alpha (Human rDNA derived) WHO International Standard |
|
|
詳細(xì)
|
| Influenza Antigen A/Texas/36/91 |
|
|
詳細(xì)
|
| Influenza anti A/Philippine/2/82 Serum |
|
|
詳細(xì)
|
| Influenza Antigen A/Michigan/45/2015 (NYMC X-275) |
|
|
詳細(xì)
|
| Ins(1,3,4,5)P4 Beads |
|
|
詳細(xì)
|
| JAM-A, domain 2, Human, pAb, 20 ug |
|
|
詳細(xì)
|
| Influenza Antigen B/Yamanashi/166/98 |
|
|
詳細(xì)
|
| JA | Jasmonic acid |
|
|
詳細(xì)
|
| Interleukin-6 (Human, rDNA derived) WHO International Standard |
|
|
詳細(xì)
|
| Jacalin-Sepharose |
|
|
詳細(xì)
|
| IRL 1620 (Endothelin B Receptor Agonist) |
|
|
詳細(xì)
|
| Internal Standard, lyophil., for Mycophenolic Acid for TDM Platform, Add-on Set-order no. MS99100 |
|
|
詳細(xì)
|
| Isovaleric-d9 acid ≥98 atom % D, ≥97% (CP) |
|
|
詳細(xì)
|
| Influenza Virus infectious A/Sichuan/346/98 (H3N2) |
|
|
詳細(xì)
|
| IndividualCalibrationSolutions |
|
|
詳細(xì)
|
| Influenza Antigen A/Brazil/11/78 |
|
|
詳細(xì)
|
| Influenza Virus Infectious B/Maryland/15/2016 42800 E5 |
|
|
詳細(xì)
|
| Influenza Virus infectious NIB-27 (H1N1) |
|
|
詳細(xì)
|
| Influenza Antigen A/New Caledonia/20/99 |
|
|
詳細(xì)
|
| Interleukin-17 (Human rDNA derived)(WHO Reference Reagent) |
|
|
詳細(xì)
|
| Interleukin-2 Soluble Receptor (human, rDNA derived) |
|
|
詳細(xì)
|
| JAM-A, domain 1, Human, pAb, 20 ug |
|
|
詳細(xì)
|
| JAM-A, domain 2, Human, pAb, 100 ug |
|
|
詳細(xì)
|
| Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6 |
|
|
詳細(xì)
|
| JAM-A, domain 1, Human, pAb, 100 ug |
|
|
詳細(xì)
|
| Interferon alpha (Human, leukocyte derived)WHO International Standard |
|
|
詳細(xì)
|
| Internal Standard IS, lyophil. for Vitamins B1, B2, B6 in Whole Blood (MS13000) |
|
|
詳細(xì)
|
| Internal Standard Epimers-Mix |
|
|
詳細(xì)
|
| Influenza anti B/ Neuraminidase Serum |
|
|
詳細(xì)
|
| Laminin Rhodamine (mouse tumor) |
|
|
詳細(xì)
|
| Lactoferrin, Bovine, pAb, 20 ug |
|
|
詳細(xì)
|
| Lipopolysaccharides from Salmonella livingstone |
|
|
詳細(xì)
|
| LL-37/CAP-18, Human, mAb 3D11, 100 ug |
|
|
詳細(xì)
|
| KatG | catalase peroxidase (HPI), cyanobacterial |
|
|
詳細(xì)
|
| Lipopolysaccharides from Salmonella essen |
|
|
詳細(xì)
|
| LBP, Mouse, ELISA kit, 1 x 96 det. |
|
|
詳細(xì)
|
| Labeled N-Glycans, |
|
|
詳細(xì)
|
| Lipid A from E.coli, Serotype R515 (Re), 1 mg |
|
|
詳細(xì)
|
| KLH | Keyhole limpet hemocyanin, HRP-conjugated (40 μg) |
|
|
詳細(xì)
|
| L-Methionine-13C5,15N,2,3,3,4,4-d5-(methyl-d3) 99 atom % 13C, 98 atom % 15N, 98 atom % D, 95% (CP) |
|
|
詳細(xì)
|
| L-Carnitine-(methyl-13C,d3) hydrochloride 99 atom % 13C, 98 atom % D, 97% (CP) |
|
|
詳細(xì)
|
| KCNK2/TREK-1 Blocking Peptide |
|
|
詳細(xì)
|
| Lhca1 | PSI type I chlorophyll a/b-binding protein |
|
|
詳細(xì)
|
| Laminin HiLyte488? (mouse tumor) |
|
|
詳細(xì)
|
| LewisY Blood Antigen/BG8 |
|
|
詳細(xì)
|
| K-Ras4B Mutant Protein: G13S (human recombinant with 6xHis-tag) |
|
|
詳細(xì)
|
| Lipopolysaccharides from Actinobacillus pleuropneumoniae |
|
|
詳細(xì)
|
| KCNN3/KCa2.3 Blocking Peptide |
|
|
詳細(xì)
|
| Lipopolysaccharide Core, mAb WN1 222-5, 20 ug |
|
|
詳細(xì)
|
| LL-37, Human, ELISA kit, 1 x 96 det. |
|
|
詳細(xì)
|
| Lipid A from Salmonella minnesota, R595 (Re), 1 mg |
|
|
詳細(xì)
|
| LowRanger 100bp DNA Ladder |
|
|
詳細(xì)
|
| Lactoferrin, Human, pAb, 20 ug |
|
|
詳細(xì)
|
| LC-3 Pesticides Mix 17 each 50μg/mL in Methanol |
|
|
詳細(xì)
|
| Labeled ds miRNA mimics Neg Control |
|
|
詳細(xì)
|
| LAIR-1, Human, mAb NKTA255, 500 ug |
|
|
詳細(xì)
|
| KDEL | endoplasmic reticulum retention signal, ATTO 390 conjugated |
|
|
詳細(xì)
|
| Lipoproteins, Very Low Density, Human Plasma, Suitable for Cell Culture |
|
|
詳細(xì)
|
| Laminin Biotin (mouse tumor) |
|
|
詳細(xì)
|
| LAL Chromogenic Endpoint Assay, 3 x 96 det. |
|
|
詳細(xì)
|
| Lipopolysaccharides from Escherichia coli O145 |
|
|
詳細(xì)
|
| K-Ras4B Mutant Protein: K128A (human recombinant with 6xHis-tag) |
|
|
詳細(xì)
|
| KChIP2 Blocking Peptide |
|
|
詳細(xì)
|
| Latrophilin-1/LPHN1 Blocking Peptide |
|
|
詳細(xì)
|
| Lactoferrin, Human, pAb, 100 ug |
|
|
詳細(xì)
|
| Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard). |
|
|
詳細(xì)
|
| KCNK13/THIK-1 Blocking Peptide |
|
|
詳細(xì)
|